0001209191-18-014730.txt : 20180228
0001209191-18-014730.hdr.sgml : 20180228
20180228195646
ACCESSION NUMBER: 0001209191-18-014730
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krognes Steve E.
CENTRAL INDEX KEY: 0001666236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 18654067
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD, SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-26
0
0001714899
Denali Therapeutics Inc.
DNLI
0001666236
Krognes Steve E.
C/O DENALI THERAPEUTICS INC.
151 OYSTER POINT BOULEVARD, SECOND FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
CFO and Treasurer
Stock Option (right to buy)
22.16
2018-02-26
4
A
0
180000
0.00
A
2028-02-25
Common Stock
180000
180000
D
25% of the shares subject to the option will vest on February 26, 2019 and an additional 1/48 of the shares vest monthly thereafter.
/s/ Tyler Nielsen, by power of attorney
2018-02-28